GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (OTCPK:BPMUF) » Definitions » Tax Provision

BPMUF (Basilea Pharmaceutica) Tax Provision : $19.4 Mil (TTM As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica Tax Provision?

Basilea Pharmaceutica's tax provision for the six months ended in Dec. 2024 was $4.4 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2024 was $19.4 Mil.

Basilea Pharmaceutica Tax Provision Historical Data

The historical data trend for Basilea Pharmaceutica's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Tax Provision Chart

Basilea Pharmaceutica Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -0.04 0.05 -0.01 19.44

Basilea Pharmaceutica Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 -0.03 0.02 15.01 4.40

Basilea Pharmaceutica Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $19.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Basilea Pharmaceutica Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (OTCPK:BPMUF) » Definitions » Tax Provision
Comparable Companies
XSWX:BIOV XSWX:IDIA XSWX:SANN XSWX:NWRN XSWX:MOLN XSWX:XLS XSWX:RLF XSWX:EVE XSWX:ADXN XSWX:BIOEE VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
BSLNz:UK 0QNA:UK BSLN:Switzerland
Address
Hegenheimermattweg 167b, Allschwil, CHE, 4123
Website
https://www.basilea.com
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.